Kombucha Prevents Indomethacin‐Induced Enteric Damage in Wistar Rat by Enhancing Epithelial Gut Barrier and Modulating Gut Microbiota

Kombucha is a fermented beverage with high contents of antioxidants and probiotics. Enteric damage due to uncontrolled consumption of non-steroidal anti-inflammatory drugs (NSAIDs) represents a significant cause of morbidity and mortality. This study aimed to evaluate the preventive effects of kombucha against indomethacin-induced enteric damage. Wistar rats were divided into control (Ctrl), supplemented with kombucha (Komb), indomethacin-induced enteric damage (Indo), and indomethacin-induced enteric damage and supplemented with kombucha (Indo-Komb) groups. We analyzed ulcer index, histological changes, gene expression of intestinal barrier function genes, and microbiota phyla in cecal content. Kombucha supplementation reduced ulcer index and intestinal inflammation, which improved survival (<i>p</i> = 0.0291), maintained body weight, (<i>p</i> < 0.001) and avoided the drop in levels of hemoglobin, hematocrit, and erythrocytes (<i>p</i> < 0.001). Histopathological analyses of intestines revealed impaired integrity of villi with inflammatory infiltrates, which were significantly prevented with kombucha supplementation (<i>p</i> = 0.0024 and <i>p</i> = 0.0017, respectively). Rats that received kombucha upregulated the expression of tight junction genes <i>Muc2</i>, <i>Cldn1</i>, and <i>Ocln</i> (<i>p</i> = 0.027, <i>p</i> = 0.024, <i>p</i> < 0.001, respectively). The upregulation of the oxidative and inflammatory markers <i>Nos2</i>, <i>Mpo</i>, and <i>Tnf</i> was prevented by kombucha intake (<i>p</i> < 0.001). Additionally, kombucha ameliorated the dysbiosis in indomethacin-induced enteric damaged rats by reduction of <i>Proteobacteria</i> (<i>p</i> < 0.001) while increasing <i>Firmicutes</i> abundance. This study demonstrated that kombucha consumption is a viable strategy to delay NSAID-induced enteric damage through enhancement of intestinal barrier integrity and prevention of dysbiosis.

Authors

Institutions

Publication Details

Journal
Food Science & Nutrition
Published
2025-08-01
DOI
https://doi.org/10.1002/fsn3.70804
Citations
1
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Kombucha Prevents Indomethacin‐Induced Enteric Damage in Wistar Rat by Enhancing Epithelial Gut Barrier and Modulating Gut Microbiota

Ma. Consolación Martínez‐Saldaña, Mariela Jiménez, Eva Salinas, Laura Elena Córdova-Dávalos et al.
1 citations
Food Science & Nutrition
Gut microbiota and health
0.81
article

Kombucha Prevents Indomethacin‐Induced Enteric Damage in Wistar Rat by Enhancing Epithelial Gut Barrier and Modulating Gut Microbiota

Ma. Consolación Martínez‐Saldaña, Mariela Jiménez, Eva Salinas, Laura Elena Córdova-Dávalos, Daniel Cervantes‐García, Tonatiuh Barrios‐García, Atziri A. Varela‐Mendoza, Ma. Magdalena Martínez‐Flores, Melanie G. Paz‐Jiménez, Fernanda García‐Acevedo, Valeria Salinas‐Guardado
article en
1 citations

Abstract

Kombucha is a fermented beverage with high contents of antioxidants and probiotics. Enteric damage due to uncontrolled consumption of non-steroidal anti-inflammatory drugs (NSAIDs) represents a significant cause of morbidity and mortality. This study aimed to evaluate the preventive effects of kombucha against indomethacin-induced enteric damage. Wistar rats were divided into control (Ctrl), supplemented with kombucha (Komb), indomethacin-induced enteric damage (Indo), and indomethacin-induced enteric damage and supplemented with kombucha (Indo-Komb) groups. We analyzed ulcer index, histological changes, gene expression of intestinal barrier function genes, and microbiota phyla in cecal content. Kombucha supplementation reduced ulcer index and intestinal inflammation, which improved survival (<i>p</i> = 0.0291), maintained body weight, (<i>p</i> < 0.001) and avoided the drop in levels of hemoglobin, hematocrit, and erythrocytes (<i>p</i> < 0.001). Histopathological analyses of intestines revealed impaired integrity of villi with inflammatory infiltrates, which were significantly prevented with kombucha supplementation (<i>p</i> = 0.0024 and <i>p</i> = 0.0017, respectively). Rats that received kombucha upregulated the expression of tight junction genes <i>Muc2</i>, <i>Cldn1</i>, and <i>Ocln</i> (<i>p</i> = 0.027, <i>p</i> = 0.024, <i>p</i> < 0.001, respectively). The upregulation of the oxidative and inflammatory markers <i>Nos2</i>, <i>Mpo</i>, and <i>Tnf</i> was prevented by kombucha intake (<i>p</i> < 0.001). Additionally, kombucha ameliorated the dysbiosis in indomethacin-induced enteric damaged rats by reduction of <i>Proteobacteria</i> (<i>p</i> < 0.001) while increasing <i>Firmicutes</i> abundance. This study demonstrated that kombucha consumption is a viable strategy to delay NSAID-induced enteric damage through enhancement of intestinal barrier integrity and prevention of dysbiosis.

Food Science & NutritionVol. 13(8)
Autonomous University of Aguascalientes (MX), Secretaria de Salud (MX)
Universidad Autónoma de Aguascalientes
Openalex Percentile: Top 25%
Gut microbiota and health
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.